Renew Democracy Initiative Proposes Legal Means to Deploy Frozen Russian Assets for Ukraine’s Benefit

NEW YORK, June 5, 2023 /PRNewswire/ — The Renew Democracy Initiative announces its plan to commission a comprehensive study of the legal foundations for seizing frozen Russian assets and transferring them to Ukraine. The Making Putin Pay initiative aims to rectify the destruction caused…

LOCUS ROBOTICS PRÄSENTIERT DIE LOCUS ORIGIN AMRS UND LocusONE WAREHOUSE AUTOMATION PLATFORM AUF DER DELIVER 2023 IN AMSTERDAM

Führender Anbieter von autonomen mobilen Robotern bietet innovative, vollständig integrierte und datenwissenschaftlich gestützte Automatisierungsplattform für die Orchestrierung mehrerer Roboterformfaktoren in großen Lagern an AMSTERDAM, 5. Juni 2023 /PRNewswire/ — Locus Robotics, ein…

Chambers Ranks Weiner Brodsky Kider PC and Mitchel H. Kider in the 2023 Guide

WASHINGTON, June 5, 2023 /PRNewswire/ — Weiner Brodsky Kider PC is pleased to announce that the firm and Mitch Kider have earned distinguished rankings by Chambers. “We are proud to be included on this elite list,” said Mitch Kider, Managing Partner, Weiner Brodsky Kider PC. “Our depth…

Servier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual Grade 2 IDH-Mutant Diffuse Glioma

Vorasidenib demonstrated an unprecedented improvement in progression free survival with a median of 27.7 months in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation; key secondary endpoint of time to next intervention significantly improved in the vorasidenib arm…

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

Nivolumab added to AVD chemotherapy expected to become new standard for initial treatment for advanced stage disease in adolescents and adults, based on trial data to be presented at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session LOS ANGELES and PORTLAND,…

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023

LUMAKRAS ® (sotorasib) Demonstrated Delayed Time to CNS Progression, Longer CNS PFS and Higher Intracranial ORR vs Docetaxel in Post-Hoc Analysis of Phase 3 CodeBreaK 200 Trial LUMAKRAS Shows Improved PFS vs Docetaxel Across Key Co-Alteration Subgroups in the Phase 3 CodeBreaK 200 Study…

Crocodile Was Top Predator At Newly Opened Prehistoric Site In Colorado

MORRISON, Colo., June 4, 2023 /PRNewswire/ — The landlocked state known for its towering Rocky Mountains and sprawling plains once featured dramatically different landscapes as seen in its geological formations. One of the more astonishing prehistoric Colorado sites is in Morrison on…

Dorsett Wanchai Marks World Environment Day 2023 with Bold Paperless and Plastic-Free Sustainability Initiatives

HONG KONG, June 4, 2023 /PRNewswire/ — The 4.5-star award-winning Dorsett Wanchai, Hong Kong is proud to lead the way for sustainability with its ‘GoGreen Promise’ and a series of paperless and plastic-free sustainability initiatives. As the Grand Award winner of the Hong Kong…

Sanyou launches new European offices and continues to promote global business landscape

SHANGHAI, June 3, 2023 /PRNewswire/ — In May 2023, following the CIC Boston branch in US, Sanyou opens new offices in The Shard London and CIC Rotterdam respectively, to rapidly promote the globalization of business landscape. Headquartered in Shanghai China, Sanyou Biopharmaceuticals Co….

Intensity Therapeutics’ INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas

Compared To Synthetic Controls, INT230-6 Alone Extended Survival In Refractory Soft Tissue Sarcoma Subjects by Nearly 450 Days With Favorable Safety INT230-6, a Locally Delivered Cytotoxic Treatment Leading to a Systemic Immune Response in Hot or Cold Tumors, Is A New Way To Treat Sarcoma…

« Previous PageNext Page »